LOGIN
Nabilone safe and effective in pain reduction in combination with gabapentin compared to placebo
September 2018
Nabilone safe and effective in pain reduction in combination with gabapentin compared to placebo
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial
Pain Med. 2015 Jan;16(1):149-59. doi: 10.1111/pme.12569Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Current convention in managing neuropathic pain (NPP) from relapsing-remitting multiple sclerosis (RRMS) often involves gabapentin (GBP) as first-line therapy and cannabis (CB) as an alternative, had other therapies not worked. The combination of GBP and CB has not been explored. In this study, 15 patients with NPP from RRMS and still experience considerable pain after a stable dosage of GBP were ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.